centenarian population
Longevity Science vs Genetic Tests - The Costly Myth
Longevity science is not a cheap shortcut; while genetic tests promise personalized risk, the reality is that the cost of developing, validating, and delivering anti-aging therapies far exceeds the modest savings from genetic screening. By 2035, U.S. centenarians are projected to double, a 100% increase that could add $70